IL18 and cancer: The most enriched and significant discoveries from late stages, on the other hand, monoclonal antibodies (p < 3.33 × 10−16, FDR < 1.25 × 10−14) by 26 genes, Epstein–Barr virus infection (p = 6.66 × 10−16, FDR = 7.60 × 10−13) by 20 genes, pathways in cancer (p = 1.22 × 10−15, FDR = 1.16 × 10−12) by 29 genes, immunoglobulins (p = 7.99 × 10−15, FDR = 5.70 × 10−12) by 32 genes, and the IL-18 signalling pathway (p = 3.89 × 10−13, FDR = 2.46 × 10−10) by 20 genes.